Reach Us +1-217-403-9671
In-Vitro Release And Pharmacokinetics Of Anti-tubercle Drug Ethionamide In Healthy Male Subjects | 8378
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

In-Vitro Release and Pharmacokinetics of Anti-tubercle drug Ethionamide in Healthy male Subjects

International Conference & Exhibition Bioequivalence and Bioavailability

Mahmood Ahmad, Asad Ullah Madni, Muhammad usman

ScientificTracks Abstracts: J Bioequiv Availab

DOI: 10.4172/0975-0851.1000001

T he aim of study was to assess the pharmacokinetics of ethionamide in the local population of healthy human subjects. Serum samples were taken from each of the selected subject at different time intervals. These samples were analyzed by using High Performance Liquid Chromatography consisting of reverse phase C18 column, UV detector set at 291nm. The mobile phase was consisted of 0.02 M disodium hydrogen phosphate and acetonitrile (75:25) and delivered at a rate of 1.5ml/min. The value of C max was found to be 1.941 ? 1.487 μg/ml (mean ? SEM) and T max was 1.75 ? 1.487 hours (mean ? SEM). The area under the curve (AUC) was 8.745 ? 0.536 (mean ? SEM). The elimination half life (t 1/2 ) was found out as 1.995 ? 1.157 hours (mean ? SEM). The total body clearance (Cl) was determined as 32.591 ? 0.298 ml/hr/kg (mean ? SEM). It was concluded that ethionamide (Ethomid ? Schazoo-Lahore, Pakistan) found in consistent with the values reported in the available literature. The study will be beneficial and valuable in designing dosage regimen for the patients on ethionamide therapy and can be utilized as guideline in accessing the bioavailability and pharmacokinetics parameters in clinical situations